20802-16-8

Upstream product

• 20802-15-7 1-(3,4-dimethoxyphenyl)cyclopropanecarbonitrile 

Downstream Products

• 70522-14-4 (3aS*,7aS*)-1-benzyl-3a,4,5,6,7,7a-hexahydro-3a-(3',4'-dimethoxyphenyl)-6-oxoindoline 
• 468-53-1 (-)-mesembrine 
• 20802-17-9 1-(3,4-Dimethoxy-phenyl)-1-methyl-iminomethyl-cyclopropan 

Relevant academic research and scientific papers

SUBSTITUTED UREA-OCTAHYDROINDOLS AS ANTAGONISTS OF MELANIN CONCENTRATING HORMONE RECEPTOR 1 (MCH1R)

The invention relates to compounds of the general formula (I). (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, and X are as defined in the description, or pharmaceutically acceptable salts, hydrates, geometrical isomers, racemates, tautomers, optical isomers, N-oxides and prodrug forms thereof. The compounds may be used for the treatment or prophylaxis of disorders related to the MCH1R receptor and for modulation of appetite. The invention also relates to such use as well as to pharmaceutical formulations comprising a compound of formula (I).

Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R)

The invention relates to compounds of the general formula (I) wherein R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, Ar, and X are as defined in the description, or a pharmaceutically acceptable salt, hydrates, geometrical isomers, racemates, tautomers, optical isomers, N-oxides and prodrug forms thereof. The compounds may be used for the treatment or prophylaxis of disorders related to the MCH1R receptor and for modulation of appetite. The invention also relates to such use as well as to pharmaceutical formulations comprising a compound of formula (I).